Expert Guidance on Harnessing New Therapeutic Approaches in Ulcerative Colitis

The introduction of S1P receptor modulators and JAK inhibitors for UC has the potential to revolutionize the therapeutic landscape. Join us as expert faculty discuss the place in therapy for these agents to help improve clinical and patient-oriented health outcomes.

Share

Program Content

Activities

Slides on New Approaches in UC
Expert Guidance on Harnessing New Therapeutic Approaches in Ulcerative Colitis Slideset
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2023

View Activity

Activities

On-Demand: New Approaches in UC
Expert Guidance on Harnessing New Therapeutic Approaches in Ulcerative Colitis
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 02, 2023

Expires: November 01, 2024

View Activity

Activities

Harnessing Small Molecules for UC
Insights on Newer Oral Therapy Options for Ulcerative Colitis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 22, 2023

Expires: November 21, 2024

View Activity

Faculty

cover img faculity

Marla Dubinsky, MD

Professor of Pediatrics and Medicine
Chief, Division of Pediatric GI and Nutrition
Co-Director, Susan and Leonard Feinstein IBD Center
Icahn School of Medicine, Mount Sinai New York
New York, New York

cover img faculity

Corey Siegel, MD, MS

Director, Center for Digestive Health
Section Chief, Gastroenterology and Hepatology
Co-Director, Inflammatory Bowel Disease Center
Dartmouth Hitchcock Medical Center
Constantine and Joyce Hampers Professor of Medicine
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Pfizer, Inc.

Pfizer, Inc.